Clinical Trial Update: Effect of Bosentan in Patients With Metastatic Melanoma Treated With Dacarbazine (DTIC) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating bosentan in patients with metastatic melanoma treated with dacarbazine (DTIC) has completed; Actelion sponsored the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Dacarbazine (DTIC) (dacarbazine)
• TRACLEER (bosentan)

Snippet

Sponsor: Actelion | Conditions: Melanoma | Phase 2 | Status: COMPLETED